GlassScriptPhysician profile
Kyle D Bond
NPI 1215522032
$1,266.90
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $365 · 2022: $158 · 2023: $418 · 2024: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $181.73 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $145.67 | 2021-2023 | Farxiga |
| Biohaven Pharmaceuticals, INC. | $132.46 | 2021 | |
| Ethicon US, LLC | $127.37 | 2022-2024 | Evarrest, Stratafix |
| Novo Nordisk INC | $108.66 | 2022-2023 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $103.16 | 2023 | Spravato |
| Bard Peripheral Vascular, INC. | $102.94 | 2024 | Rotarexs 6 F X 135 Cm |
| Tactile Systems Technology INC | $99.95 | 2024 | Flexitouch Plus, Entre Plus |
| Merck Sharp & Dohme LLC | $67.05 | 2022-2023 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
| Idorsia Pharmaceuticals US INC | $34.01 | 2023 | Quviviq |
| Glaxosmithkline, LLC. | $31.27 | 2021-2023 | Trelegy Ellipta |
| Resmed Corp | $24.36 | 2021 | |
| Exact Sciences Corporation | $22.37 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $21.38 | 2021 | |
| Organogenesis INC. | $21.17 | 2024 | Nushield |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $15.59 | 2021 | |
| Hologic Sales and Service, LLC | $14.49 | 2021 | |
| Pfizer INC. | $13.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Bond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.